Production (Stage)
Centessa Pharmaceuticals plc
CNTA
$12.60
$0.221.78%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 284.51M | 482.18M | 518.45M | 294.83M | 230.18M |
| Total Receivables | 52.70M | 45.30M | 40.04M | 46.99M | 37.18M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 375.00K | 840.00K | 1.37M | 56.00K | 716.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 10.13M | 8.10M | 8.51M | 13.62M | 16.41M |
| Total Current Assets | 347.72M | 536.41M | 568.36M | 355.50M | 284.48M |
|
|
|||||
| Total Current Assets | 347.72M | 536.41M | 568.36M | 355.50M | 284.48M |
| Net Property, Plant & Equipment | 11.46M | 11.76M | 12.07M | 12.37M | 12.65M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 28.27M | 28.63M | 29.29M | 30.97M | 31.05M |
| Total Assets | 527.85M | 576.80M | 609.72M | 398.85M | 328.17M |
|
|
|||||
| Total Accounts Payable | 5.13M | 7.14M | 7.44M | 5.32M | 7.50M |
| Total Accrued Expenses | 16.85M | 49.31M | 17.97M | 20.24M | 18.88M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 629.00K | 602.00K | 577.00K | 552.00K | 528.00K |
| Total Finance Division Other Current Liabilities | 1.59M | 943.00K | 413.00K | 644.00K | 528.00K |
| Total Other Current Liabilities | 1.59M | 943.00K | 413.00K | 644.00K | 528.00K |
| Total Current Liabilities | 24.20M | 58.00M | 26.41M | 26.76M | 27.44M |
|
|
|||||
| Total Current Liabilities | 24.20M | 58.00M | 26.41M | 26.76M | 27.44M |
| Long-Term Debt | 109.25M | 108.94M | 75.70M | 76.50M | 76.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.12M | 8.29M | 8.44M | 8.60M | 8.74M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 29.00K | 29.00K | 29.00K | 29.00K | 29.00K |
| Total Liabilities | 141.60M | 175.25M | 110.58M | 111.88M | 113.01M |
|
|
|||||
| Common Stock & APIC | 1.40B | 1.39B | 1.37B | 1.12B | 1.00B |
| Retained Earnings | -1.01B | -988.70M | -877.37M | -834.81M | -790.99M |
| Treasury Stock & Other | 2.08M | 4.21M | 2.10M | 1.60M | 1.62M |
| Total Common Equity | 386.25M | 401.55M | 499.14M | 286.97M | 215.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 386.25M | 401.55M | 499.14M | 286.97M | 215.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 386.25M | 401.55M | 499.14M | 286.97M | 215.16M |
|
|
|||||